Status:

UNKNOWN

Comparing an Intraoperative vs. a Standard Wavefront Device

Lead Sponsor:

Prim. Prof. Dr. Oliver Findl, MBA

Conditions:

Cataract

Eligibility:

FEMALE

21-105 years

Phase:

NA

Brief Summary

Comparison of intraoperative measured wavefront data with pre- and post-operative wavefront data.

Detailed Description

Different technologies are in use for measuring wavefront aberrations, such as Hartmann-Shack wavefront aberrometry, Tscherning aberrometry, Laser Raytracing and automatic retinoscopy. While Hartmann-...

Eligibility Criteria

Inclusion

  • Cataract
  • Age 21 and older
  • Able to understand the patient information
  • Willing to follow the instructions and attend all follow-up visits
  • Willing to sign informed consent prior to surgery

Exclusion

  • Relevant other ophthalmic diseases that are likely to reduce the refractive outcome, such as pseudoexfoliation syndrome, traumatic cataract, severe corneal scars
  • Previous ocular surgeries on the study eye
  • Patients who are not able to cooperate, with eccentric fixation or insufficient ability to fixate (tremor, nystagmus)
  • Pregnant or lactating women (pregnancy testing will be performed preoperatively on women of reproductive age)

Key Trial Info

Start Date :

September 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2019

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT03749798

Start Date

September 1 2018

End Date

December 1 2019

Last Update

November 23 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Vienna Institute for Research in Ocular Surgery (VIROS)

Vienna, Austria, 1140